original ) (raw )High dose intravenous steroid therapy for severe posterior segment uveitis in Behcet's disease
Ebru Toker
British Journal of Ophthalmology, 2002
View PDFchevron_right
Uveitis in Behçet Disease in a Tertiary Center Over 25 Years: The KKESH Uveitis Survey Study Group
Hanan Shamsi
American Journal of Ophthalmology, 2015
View PDFchevron_right
Infliximab in the treatment of posterior uveitis in Behçet’s disease. Long term follow up in four patients
Nicolas Lanthier
La Presse Médicale
View PDFchevron_right
Uveitis in Behçet disease: An analysis of 880 patients
Ilknur Tugal-tutkun
American Journal of Ophthalmology, 2004
View PDFchevron_right
Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's Disease
Paola Pezzi
Japanese Journal of Ophthalmology, 2007
View PDFchevron_right
Infliximab in the treatment of posterior uveitis in Behçet's disease
Nicolas Lanthier
La Presse Médicale, 2005
View PDFchevron_right
The Effectiveness of Pre- and Postoperative Infliximab in Controlling Behçet’s Disease Posterior Uveitis in Patients Undergoing Vitrectomy: A Preliminary Study
Heba El Gendy
Journal of Ophthalmology, 2017
View PDFchevron_right
Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
Siamak Sabour
Journal of Ophthalmic and Vision Research
View PDFchevron_right
Clinical Study Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet ’ s Disease
Jelena Paovic
2015
View PDFchevron_right
Correlation between Ocular Manifestations and Their Complications as Opposed to Visual Acuity and Treatment in Behcet's Disease
Jelena Paović
Autoimmune diseases, 2013
View PDFchevron_right
Role of Immunomodulatory and Biological Therapy in the Treatment of Patients with Behcet's Uveitis -Cases from Clinical Practice
Filip Gucev
Journal of Morphological Sciences, 2022
View PDFchevron_right
Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years
Farhad Shahram
International Journal of Rheumatic Diseases, 2013
View PDFchevron_right
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease
Giuseppe Lopalco
The Israel Medical Association journal : IMAJ, 2017
View PDFchevron_right
Ocular manifestations and complications in a cohort of Behçet’s disease patients in a tertiary hospital
ahmed ebeid
The Egyptian Rheumatologist, 2021
View PDFchevron_right
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study
G. Gini , Maurizio Benucci
Rheumatology, 2007
View PDFchevron_right
Characteristics of Ocular Behçet Disease: A Retrospective Study
Imane Chabbar
Saudi Journal of Medical and Pharmaceutical Sciences, 2020
View PDFchevron_right
C 47 Evaluation criteria of uveitis in Behçet's disease
M Hamza
La Revue de Médecine Interne, 1993
View PDFchevron_right
Late-onset Behçet’s disease: demographic, clinical, and ocular features
Emre Hekimoğlu
Graefe's Archive for Clinical and Experimental Ophthalmology, 2010
View PDFchevron_right
Ocular, Systemic Manifestations and Efficacy of Treatment of Behcet's Disease Patients at King Hussein Medical Center
Ahmed Khatatbeh
Journal of the Royal Medical Services, 2017
View PDFchevron_right
Infliximab in the treatment of posterior uveitis in Beh�et's disease
Nicolas Lanthier
Presse Medicale, 2005
View PDFchevron_right
Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
Vicktoria Vishnevskia-Dai
Biomedicines
View PDFchevron_right
Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years
Seyedeh Faezi
Clinical Rheumatology, 2011
View PDFchevron_right
Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases
Ilknur Tugal-tutkun
American Journal of Ophthalmology, 2003
View PDFchevron_right
How Much Improvement is Expected in Ocular Lesions of Behcet's Disease Treated with Pulse Cyclophosphamide?
Farhad Shahram
2005
View PDFchevron_right
Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)
Farhad Shahram
International Journal of Rheumatic Diseases, 2010
View PDFchevron_right
Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease, National multicenter study of 177 cases
Ricardo Blanco
Arthritis & Rheumatology
View PDFchevron_right
Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
Hatem Kalantan
Annals of Saudi medicine
View PDFchevron_right
A Double-masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease
Chi-chao Chan
Ocular Immunology and Inflammation, 2007
View PDFchevron_right